ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Blood cancer treatment called ‘revolutionary’ after all study patients responded – kgw.com

Continue reading

2017-06-06 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Trading Up – Insiders Are Buying and Selling – Finance Daily


kgw.com

Blood cancer treatment called ‘revolutionary’ after all study patients responded
kgw.com
Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small — 35 people — every patient responded and all but two were in some level …

and more »

Continue reading

2017-06-06 Michael Zand NEWS

CRISPR DNA Editing Can Cause Hundreds of Off-Target Mutations – Seeker

SeekerCRISPR DNA Editing Can Cause Hundreds of Off-Target MutationsSeekerComputer illustration showing the molecular structure of the CRISPR-associated protein Cas9 in complex with RNA (ribonucleic acid, red) and DNA (deoxyribonucleic acid, orange-fuch… Continue reading

2017-06-06 Michael Zand NEWS

Sowing Stem Cells: Lab-Grown Organoids Hold Promise for Patient Treatments – UCSF News Services

UCSF News ServicesSowing Stem Cells: Lab-Grown Organoids Hold Promise for Patient TreatmentsUCSF News ServicesUsing stem cells from patients with craniofacial deformities, Klein, Bush, Pomerantz, Knox, Hsiao, and their colleagues are growing tiny funct… Continue reading

2017-06-06 Michael Zand NEWS

Immunotherapy may slow growth of relapsed mesothelioma – Healio

Editas Medicine, Inc. (NASDAQ:EDIT) Trading Up – Insiders Are Buying and Selling
Finance Daily
CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular …

Continue reading

2017-06-06 Michael Zand NEWS

Doctors Targets Stem Cell Therapy Launch – Bahamas Tribune

Immunotherapy may slow growth of relapsed mesothelioma
Healio
“Our findings suggest that immunotherapy may provide new hope to patients with relapsed mesothelioma,” Arnaud Scherpereel, MD, PhD, head of the pulmonary and thoracic oncology department at University Hospital of Lille in France, said in a press …

and more »

Continue reading

2017-06-06 Michael Zand NEWS

CAR T-Cell Therapy Effective in Multiple Myeloma – Cancer Network

Doctors Targets Stem Cell Therapy Launch
Bahamas Tribune
#Doctors Hospital’s 2017 annual report did not identify the types of stem cell treatment involved, but said: “It is envisioned that stem cell therapy will occur at the facility [Bahamas Medical Centre] in fiscal 2018, with one programme already …

Continue reading

2017-06-06 Michael Zand NEWS

Early Results Show High Response Rate Achieved With BCMA CAR T-cell Therapy in Multiple Myeloma – Targeted Oncology

NBCNews.comEarly Results Show High Response Rate Achieved With BCMA CAR T-cell Therapy in Multiple MyelomaTargeted OncologyTreatment with chimeric antigen receptor (CAR) T cells that target B-cell maturation protein (BMCA) achieved clinical remissions … Continue reading

2017-06-06 Michael Zand NEWS
  • 1
  • …
  • 1,645
  • 1,646
  • 1,647
  • 1,648
  • 1,649
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Daily Mail

CAR T-Cell Therapy Effective in Multiple Myeloma
Cancer Network
A new type of immunotherapy—chimeric antigen receptor (CAR) T-cell therapy targeting B-cell maturation protein (BCMA)—may be a new effective type of treatment for patients with multiple myeloma, according to the results of a single-arm study …
Early Results Show High Response Rate Achieved With BCMA CAR T-cell Therapy in Multiple MyelomaTargeted Oncology
ASCO: CAR T-Cell Therapy Promising in Multiple MyelomaDoctors Lounge
New cell therapy offers hope of a leukaemia cure: Early trial of pioneering treatment eradicated the disease in 94 …Daily Mail
WBRC FOX6 News – WBRC.com –The Sunday Post
all 15 news articles »